Tower Research Capital LLC (TRC) - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 39 filers reported holding LIANBIO in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of LIANBIO
ValueSharesWeighting
Q2 2023$2,002
+14200.0%
878
-89.7%
0.00%
-100.0%
Q4 2022$14
-100.0%
8,519
-59.0%
0.00%0.0%
Q3 2022$41,000
+1266.7%
20,773
+1695.4%
0.00%
Q2 2022$3,000
-86.4%
1,157
-80.4%
0.00%
Q1 2022$22,0005,9030.00%
Other shareholders
LIANBIO shareholders Q3 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,282,084$4,929,0004.16%
Perceptive Advisors 56,560,211$122,170,0003.83%
SCHF (GPE), LLC 937,500$2,025,0002.99%
VR Adviser, LLC 5,378,341$11,617,0002.29%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,314,173$7,159,0000.52%
Affinity Asset Advisors, LLC 450,000$972,0000.41%
Altium Capital Management LP 315,191$681,0000.27%
RA Capital Management 4,622,574$9,985,0000.27%
22NW, LP 141,223$305,0000.16%
Logos Global Management LP 394,486$852,0000.16%
View complete list of LIANBIO shareholders